HARVARD BIOSCIENCE, INC. Increase (Decrease) in Accounts Payable
HARVARD BIOSCIENCE, INC. (HBIO) reported Increase (Decrease) in Accounts Payable of $511.00 thousand for the 12-month period ending 2020-12-31, per its 10-K/A filed 2021-03-17.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2021-03-17
- HARVARD BIOSCIENCE, INC. increase (decrease) in accounts payable for the quarter ending 2020-12-31 was -$154.00K, a 1500.00% decline year-over-year.
- HARVARD BIOSCIENCE, INC. increase (decrease) in accounts payable for the quarter ending 2020-09-30 was -$585.00K.
- HARVARD BIOSCIENCE, INC. increase (decrease) in accounts payable for the quarter ending 2020-06-30 was -$72.00K.
- HARVARD BIOSCIENCE, INC. increase (decrease) in accounts payable for the quarter ending 2020-03-31 was $1.32M.
- HARVARD BIOSCIENCE, INC. increase (decrease) in accounts payable for fiscal 2020 was $511.00K.
- HARVARD BIOSCIENCE, INC. increase (decrease) in accounts payable for fiscal 2019 was -$2.05M, a 228.56% decline from fiscal 2018.
- HARVARD BIOSCIENCE, INC. increase (decrease) in accounts payable for fiscal 2018 was $1.59M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$154.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-03-17 | -$739.00K derived: sum of 2 quarters · filed 2021-03-17 | -$811.00K derived: sum of 3 quarters · filed 2021-03-17 | $511.00K 10-K/A · filed 2021-03-17 |
| 2020-09-30 | -$585.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$657.00K derived: sum of 2 quarters · filed 2020-11-06 | $665.00K 10-Q · filed 2020-11-06 | $676.00K derived: sum of 4 quarters · filed 2021-03-17 |
| 2020-06-30 | -$72.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $1.25M 10-Q · filed 2020-08-10 | $1.26M derived: sum of 3 quarters · filed 2021-03-17 | $584.00K derived: sum of 4 quarters · filed 2021-03-17 |
| 2020-03-31 | $1.32M 10-Q · filed 2020-05-08 | $1.33M derived: sum of 2 quarters · filed 2021-03-17 | $656.00K derived: sum of 3 quarters · filed 2021-03-17 | -$608.00K derived: sum of 4 quarters · filed 2021-03-17 |
| 2019-12-31 | $11.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-03-17 | -$666.00K derived: sum of 2 quarters · filed 2021-03-17 | -$1.93M derived: sum of 3 quarters · filed 2021-03-17 | -$2.05M 10-K/A · filed 2021-03-17 |
| 2019-09-30 | -$677.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$1.94M derived: sum of 2 quarters · filed 2020-11-06 | -$2.06M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | -$1.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$1.38M 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | -$118.00K 10-Q · filed 2020-05-08 | |||
| 2018-12-31 | $1.59M 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |